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Abstract
Head and neck tumorigenesis has been postulated to
represent a multistep process driven by the accumulation
of carcinogen-induced genetic changes throughout the
exposed tissue field. To better explore this genetic
instability process at the tissue level, 59 regions within 26
biopsy tissue specimens from individuals with oral
leukoplakia have been subjected to chromosome 9 in situ
hybridization analysis, and the degree of chromosome
instability was related to known clinical/pathological
parameters associated with tumor risk. Whereas
chromosome indices were similar between high-risk lesion
sites and low-risk lesion sites, high-risk lesions showed
higher levels of chromosome polysomy than did low-risk
sites [median PIs (polysomy indices), 2.1 versus 1.4,
respectively]. Similarly, dysplastic regions showed
significantly higher chromosome polysomy levels than
hyperplastic regions (median PIs, 2.4 versus 1.5,
respectively). Interestingly, however, hyperplastic regions
in the same biopsy as dysplastic regions showed two-times
higher polysomy levels than those in biopsies without
dysplasia (median PIs, 2.6 versus 1.3, respectively),
suggesting that chromosome polysomy determinations
provide a field measurement for the degree of ongoing
genetic insult. Finally, chromosome polysomy tended to
persist or increase in the superficial epithelial layers in
regions showing koilocytosis, whereas their frequency
decreased in nonkoilocytotic regions, suggesting that
epigenetic factors may serve to perpetuate the levels of
genetically unstable cells in the epithelium. These results
provide direct support for the field cancerization process
and suggest that measurements of genetic instability
might provide additional biological information beyond
histology and lesion site characteristics in the assessment
of head and neck cancer risk.
Introduction
Despite the introduction of novel therapeutic modalities into the
treatment of human head and neck cancer, improvements in long-
term survival rates have only been modest (1). As a result, there
has been increasing interest in the development of chemopreven-
tive strategies to slow or stop the onset of invasive disease (2, 3).
However, such chemopreventive trials have been limited by a
number of factors, including the inability to identify high-risk
groups and the extended period of risk before cancer onset (4). As
a result, chemoprevention trials using cancer incidence as a pri-
mary end point require the inclusion of large numbers of subjects
and long follow-up times. To overcome these limitations, recent
clinical trials have focused on short-term histological and biomar-
ker end points in subjects with modest cancer risk (5, 6). Oral
leukoplakia/erythroplakia has been considered a premalignant
condition because its presence places the individual at increased
cancer risk. However, the overall incidence of cancer development
in subjects with oral leukoplakia is in the range of 4.4 to 17.5% in
different studies (7, 8). When histological evidence of moderate to
severe dysplasia is present, the incidence of cancer development
substantially increases to 36% (9). Although histological evidence
of epithelial dysplasia is still the most important predicator for
cancer risk, epithelial histological appearance is not always pre-
dictive of individual patient outcome; e.g., the cancer risk is still
significant in subjects with hyperplasia and mild dysplasia, and
many individuals with severe dysplasia show persistent stability
for many years. Moreover, the site of head and neck cancer
frequently occurs away from the oral leukoplakia lesions. There-
fore, there is a need for the development of objective biomarkers
that can augment histological risk assessment and can provide
cancer risk information for the whole tissue field.
Because of its association with tobacco and alcohol expo-
sure, head and neck tumorigenesis has been proposed to rep-
resent a multistep process involving the accumulation of ge-
netic alterations in the carcinogen-exposed field (10, 11). This
hypothesis is supported by the frequent presence of premalig-
nant lesions in the epithelial field of head and neck cancers and
the high frequency of second primary tumors in patients defin-
itively treated for their first head and neck primary tumor (12).
To examine the nature of genetic instability in the surrounding
tissue fields of head and neck tumors, our group explored
previously (13) the use of the technique of CISH4 to measure
the frequency of chromosome polysomy (i.e., the frequency of
cells with three or more chromosome copies) in head and neck
tumors and their adjacent premalignant lesions. These studies
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demonstrated that chromosome polysomy could be detected in
histologically normal epithelium in the field of head and neck
tumors and that the degree of genetic instability appeared to
increase as the tissue progressed through a histological progres-
sion from normal to hyperplasia to dysplasia to tumor. In
contrast, chromosome polysomy was rarely observed in normal
epithelium of control subjects.
The premalignant lesions adjacent to the cancer described
above represented epithelium in a 100% tumor risk field. There-
fore, it was of interest to determine whether genetic instability
could be detected in oral premalignant lesions in subjects without
head and neck cancer. A subsequent limited study of 13 subjects
demonstrated that chromosome polysomy could be detected in
hyperplastic and dysplastic oral leukoplakia lesions (14). Whereas
the degree of evident chromosome polysomy was highly variable
between subjects, dysplastic lesions appeared to show higher lev-
els of chromosome instability than hyperplastic lesions. Of inter-
est, three of the four cases exhibiting relatively high levels of
chromosome instability in their oral leukoplakia biopsies subse-
quently developed head and neck cancer. Therefore, these pilot
results and a subsequent study (15) suggested that the measure-
ment of generalized chromosome polysomy might provide a ge-
netic marker for assessing the risk of cancer development in
subjects with oral leukoplakia.
For a biomarker to be useful for head and neck cancer risk
assessment, it should accomplish several goals. First, it should
provide information beyond that of histology. Second, it should
provide risk information for the whole epithelial tissue field at risk.
Third, it should reflect the etiological pathways driving head and
neck tumorigenesis such that it could be used as an intermediate
marker of chemopreventive effect (16). The goal of the present
study was to expand the previous experience of measuring chro-
mosome polysomy in oral leukoplakia lesions using CISH. In
particular, we wanted to better determine the relationship between
the levels of chromosome polysomy and histological progression,
and we wanted to determine whether generalized genomic insta-
bility could be detected throughout the biopsy specimen, not only
in the most histologically advanced region. The results of this
study demonstrate that, whereas dysplastic lesions generally show
higher chromosome polysomy levels than hyperplastic lesions,
hyperplastic lesions contiguous to dysplastic lesions exhibit sim-
ilar levels of genetic damage to that of dysplastic lesions. In
addition, the presence of koilocytosis was associated with the
retention of polysomic cells in the epithelium.
Materials and Methods
Tissue Materials. Oral punch biopsy specimens (4 mm in
diameter) of oral leukoplakia or erythroplakia lesions were
obtained from 26 subjects participating in an ongoing chemo-
prevention trial conducted at the M. D. Anderson Cancer Cen-
ter (17). For entry into the clinical trial, the subjects had to
exhibit clinical and histological evidence of oral leukoplakia
and/or erythroplakia. Subjects with cancer or prior cancer ther-
apy were excluded. Lesions occurring in the lateral and/or
ventral tongue, floor of mouth, or mucosal lip were considered
high-risk regions, whereas lesions occurring in the buccal mu-
cosa, gingiva, vestibule, and dorsal tongue were considered
low-risk regions. The biopsies were obtained before chemopre-
ventive treatment, fixed in buffered formalin, and embedded in
paraffin. Specimens exhibiting tangential cuts or autolysis were
excluded from the analysis.
Histological Analysis. H&E-stained slides were reviewed by
two pathologists (J. K. and A. E.). To facilitate multiple chromo-
some instability measurements on each case, two to five epithelial
regions were marked on each tissue section according to the size
of the tissue and the histological findings. Even sections showing
a uniform histology were divided into two or three regions to avoid
observer bias during chromosome polysomy analysis. A total of 59
tissue regions were identified from the 26 biopsies. Each region
was histologically characterized into one of four categories, i.e.,
hyperplasia or mild, moderate, or severe dysplasia. Dysplasia was
determined according to WHO criteria (18). In addition, the pres-
ence or absence of koilocytosis, diagnosed by a distinct perinuclear
halo and condensed, pyknotic, or angulated nuclei (19), was noted
when present.
CISH. Tissue sections (4 mm) from paraffin blocks of leuko-
plakia biopsies were placed on silane-coated slides. The slides
were placed overnight on a slide warmer at 65°C, then dewaxed
in xylene, and cleared in 100% ethanol. The slides were then
treated with 1 mg/ml RNase in 2 3 SSC and digested with 0.4%
pepsin (Sigma Chemical Co., St. Louis, MO) in 0.2 N HCl as
described previously (20).
Biotin-labeled a satellite DNA (0.8 ng/ml), specific for the
pericentromeric region of chromosome 9 (Oncor, Gaithersburg,
MD), was mixed in a hybridization solution composed of 60%
formamide in 2 3 SSC, 5% dextran sulfate, and 1 mg/ml
salmon sperm DNA. The hybridization solution was placed on
the tissue section, and the two were denatured together at 93°C
for 6 min and incubated at 37°C overnight. The next day, the
sections were washed in 50% formamide in 1 3 SSC (pH 7.0)
at room temperature twice for 15 min each, followed by wash-
ing thrice in 0.1 3 SSC at 37°C for 10 min each. The slides
were then treated with a 3% BSA-blocking solution for 10 min
and then incubated with avidin (Vector, Burlingame, CA) and,
subsequently, with antiavidin (Vector). These steps were re-
peated to amplify the signal, and then an avidin-biotin-perox-
idase complex solution was applied. Each incubation step was
carried out at 37°C for 30 min, followed by a wash with PBS.
The hybridization signals were developed with 50 mg of dia-
minobenzidine tetrahydrochloride (Sigma) and 35 mg of NiCl2
in 100 ml of PBS and counterstained with Giemsa.
Analysis of Chromosome Signals. The criteria for the scoring
of chromosome hybridization signals were as described previ-
ously (20). The levels of chromosome hybridization signals in
the lymphocytes infiltrating the submucosa served as controls
for determining the hybridization efficiencies in the epithelial
layers. Chromosome copy numbers were assessed separately in
the basal, parabasal, and superficial cell layers to determine
whether the detected degree of genetic instability was influ-
enced by cell maturation or location in the epithelium. From
100 to 900 cells were counted in each predetermined region at
31000 magnification. The CI4 for each region was calculated
by dividing the total number of signals detected by the total
number of nuclei scored. The chromosome P.I. was defined as
the percentage of scored nuclei exhibiting three or more chro-
mosome copies. Tissue sectioning results in the truncation of
nuclear material and leads to an under-representation of chro-
mosome copy number. To avoid bias, nuclei exhibiting no
signals were included in all of the calculations.
The Magiscan Image Analysis system (Joyce Loebl, Ltd.,
Dukesway, England) was used to record the spatial distribution
of chromosome counts in the epithelium (21). The relative x-
and y-coordinates and detected chromosome copy number of
each scored nucleus was recorded in list mode. This permitted
the preparation of a genetic map of the tissue section where
each nucleus is represented by a dot, the color of which rep-
resents the chromosome copy number detected for that cell.
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Statistical Analysis. The data collected did not show a normal
distribution; therefore, statistical analysis of the data was car-
ried out using nonparametric methods. The levels of genetic
instability between histological and high-risk versus low-risk
groups were compared using the Mann-Whitney test. The Wil-
coxon signed rank test was used to compare the differences in
P.I. between basal/parabasal cell layers and the superficial
epithelial layers in each region.
Results
Clinical and Histological Characteristics. Twenty-six biopsy
specimens from 26 cases were available for both clinical review
and analysis of genetic instability by CISH. As shown in Table
1, the median age of the subjects was 50 years of age, ranging
from 27 to 78 years. Eighteen of the cases were male, with a
median age of 57, whereas 8 cases were female, with a median
age of 45.5. Twenty of the 26 cases had a documented signif-
icant smoking and drinking history. The remaining cases re-
ported a negative smoking history; however, four of these six
cases did report a drinking history. The oral premalignant
lesions were located in various sites, including the lateral and/or
ventral tongue (nine cases), gingiva (four cases), buccal mucosa
(five cases), floor of mouth (three cases), vestibule (two cases),
mucosal lip (two cases), and dorsal tongue (one case). Of the 59
regions identified on the tissue sections that had adequate in situ
hybridization signals, 47 regions showed hyperplasia whereas
12 regions showed dysplasia (7 mild, 1 moderate, and 4 severe).
Fifteen of the hyperplastic regions examined occurred in the
same biopsy as documented dysplasia, i.e., either in the same
tissue section or on another tissue section deeper into the biopsy
specimen. In 14 biopsies taken from individuals with leukopla-
kia in high-risk sites (i.e., lateral and/or ventral tongue, floor of
mouth, or mucosal lip), 7 (50%) showed dysplasia somewhere
in the biopsy. In contrast, in 12 biopsies taken from individuals
with leukoplakia in low-risk sites (i.e., the buccal mucosa,
gingiva, vestibule, or dorsal tongue), only 3 biopsies (25%)
showed evidence of dysplasia (Table 2).
Chromosome Polysomy and Lesion Site. As shown in Fig. 1,
the chromosome hybridization signals appear as dark spots
associated with the nuclei. Whereas most of the nuclei showed
zero, one, or two signals/cell, in some cases, cells exhibiting
three or more signals were apparent in the epithelial cell layers.
Such cells were rarely observed in the stromal fibroblasts or
infiltrating lymphocytes. The CIs of the lymphocyte controls
ranged from 1.19 to 1.52 (median, 1.38), suggesting that the
efficiency of hybridization can vary somewhat from one reac-
tion to another. As shown in Table 2, the CIs of the basal/
parabasal epithelial layers were similar between the high-risk
and low-risk sites. This suggests that the overall C.I. of a region
might not be a sensitive biological end point for describing
genetic instability in the tissue. This observation is in line with
previous observations (22) that a significant change in the C.I.
can only be detected when more that 25% of the population is
composed of monosomic or trisomic cell populations. On the
other hand, high-risk sites showed significantly higher frequen-
cies of chromosome polysomy than that of low risk sites (Table
2). In particular, the median (range) P.I. of high-risk sites was
Fig. 1. Detection of chromosome polysomy in leukoplakia lesion showing mild
epithelial dysplasia by CISH. A, H&E of epithelium showing mild dysplasia
(3200); B, CISH of the same area of Fig. 1A illustrating cells with three
signals/cell scattered in the basal and parabasal cell layers (31000).
Table 1 Patient characteristics (n 5 26)
Age (range) 50 (27–78)
Gender
Male 18
Female 8
Lesion site
Tongue 10
Floor of mouth 3
Buccal mucosa 5
Gingiva 4
Vestibule 2
Mucosal lip 2
Smoking history
Present 20
Absent 6
Table 2 Relationship between histology and genetic instability in high- and
low-risk epithelial sites
High-risk sites
(n 5 34)
Low-risk sites
(n 5 25)
Histology
Hyperplasia 27 20
Mild dysplasia 7 0
Moderate dysplasia 0 1
Severe dysplasia 0 4
C.I.
Median (range) 1.4 (1.0–1.6) 1.4 (1.1–1.5)
P.I.
Median (range) 2.1 (0–9.3) 1.4 (0–4.2)
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2.1 (0–9.3) compared with values of 1.4 (0–4.2) in the low-risk
sites (P 5 0.147 by the Mann-Whitney test). Thus, whereas
high-risk sites tended to exhibit higher degrees of genetic
instability than did low-risk sites, considerable variability in
chromosome polysomy was observed within groups with dif-
ferent risks based on the site of disease.
Chromosome Polysomy and Histology. In general, dysplastic
regions showed a tendency for higher degrees of polysomy than
did regions exhibiting hyperplasia [median (range) PIs of 2.4
(0–8.5) versus 1.5 (0–9.3), respectively; P 5 0.135]. More-
over, the median P.I. of four regions showing severe dysplasia
was 4.0 (range, 2.9–4.2), whereas the median P.I. for the seven
lesions with mild dysplasia was 1.6 (range, 0–8.5). One lesion
with moderate dysplasia associated with lichenoid inflamma-
tion had a P.I. of 1.9. In most cases, the cells showing three
chromosome copies were randomly scattered throughout the
epithelial layers. However, in some cases with higher polysomy
levels, there appeared to be a clustering of cells with three or
more chromosome copies, perhaps suggesting the presence of a
localized clonal outgrowth (Fig. 2).
A considerable overlap of polysomy values was observed
between the various histological groupings. To better understand
the biological basis for this variability, the hyperplastic lesions
were divided into those that existed in the presence of dysplasia
elsewhere in the biopsy specimen (e.g., adjacent or deeper in the
biopsy) and those where hyperplasia represented the highest de-
gree of histological progression in the biopsy specimen (Fig. 3).
The median P.I. of hyperplastic lesions in the same biopsies as
dysplastic lesions was 2.6 (range, 0–9.3) compared with a median
P.I. of 1.3 (range, 0–4.1) in lesions where hyperplasia represented
the most advanced stage. This difference was statistically signifi-
cant by the Mann-Whitney test (P 5 0.0465). Thus, hyperplastic
lesions in the field of dysplastic lesions show chromosome insta-
bility characteristics closer to those of lesions showing dysplasia.
Such an example is shown in Fig. 4 where both the hyperplastic
region and the focally dysplastic region showed similar levels of
chromosome polysomy.
Chromosome Polysomy and Koilocytosis. During the course
of this study, a number of regions were noted to exhibit koilocy-
tosis. To determine whether koilocytosis was associated with ge-
netic instability, the levels of chromosome polysomy were com-
pared in lesions showing koilocytosis with those not showing
koilocytosis. Because koilocytosis is usually found in the more
superficial epithelial layers, the levels of chromosome polysomy
were also compared between the basal/parabasal layers and the
superficial layers in each region. A total of 59 epithelial regions
from 26 biopsies were evaluable for polysomy indices in both
basal/parabasal and superficial layers. Of these 59 regions, 23
showed signs of koilocytosis and 36 did not. The mean polysomy
levels in the basal/parabasal and the superficial layers of regions
showing koilocytosis were 1.6 and 1.6, respectively, as compared
with 2.5 and 1.5, respectively, for the regions not showing koilo-
cytosis. The higher levels of chromosome polysomy in the non-
koilocytotic regions were associated with an increased frequency
of dysplastic lesions in this group compared with the koilocytotic
lesions. On a region-by-region basis (Fig. 5), the mean difference
in P.I.s between the superficial and basal/parabasal layers in re-
gions with koilocytosis was 20.017, whereas that in regions
without evident koilocytosis was 20.94%. Moreover, 9 of the 23
(39.1%) regions with koilocytosis showed an increase of chromo-
some polysomy of greater than 0.5% in cells moving into the
superficial layers, compared with only 5 of 36 (13.8%) of the
regions without koilocytosis. Thus, whereas the regions showing
koilocytosis tended to exhibit less overall chromosome polysomy
than regions not showing koilocytosis, they tended to exhibit the
same or even higher frequencies of chromosome polysomy in the
Fig. 2. Detection of clusters of cells within the leukoplakia epithelium showing
chromosome polysomy. A, H&E of epithelial lesion showing severe dysplasia
(3100); B, CISH analysis of the same area shown in Fig. 2A showing a cluster
of cells with three chromosome 9 copies/cell (3400).
Fig. 3. Comparison of chromosome polysomy levels in epithelial lesions as a
function of histology. Note that hyperplastic lesions in the same tissue field as
dysplasia show elevated chromosome polysomy levels closer to that of dysplastic
lesions than hyperplasia lesions alone.
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more superficial layers as compared with the basal/parabasal lay-
ers. This phenomenon was documented using the Magiscan Image
Analysis system to generate chromosome copy spatial distribution
maps. As shown in Fig. 6A, cells exhibiting three or more chro-
mosome signals were dispersed throughout the epithelial thickness
with koilocytosis. In contrast, the cells showing polysomy were
preferentially distributed in the basal and parabasal layers in the
regions not showing koilocytosis (Fig. 6B).
Discussion
The risk of cancer development in subjects with oral prema-
lignant lesions is traditionally estimated by several factors
including the presence and severity of epithelial dysplasia,
smoking or alcohol exposure history, evidence for viral infec-
tion, and sites and patterns of the lesions. In particular, lesions
of the floor of mouth, lip, and tongue are considered relatively
high risk because epithelial dysplasia and subsequent cancer
development are more frequent than in other sites (23–26).
Moreover, it has been postulated that these sites are at higher
risk because of either the pooling of soluble carcinogens in the
“sump” of the floor of the mouth or the association with actinic
damage to the lip (25, 26). Because cancer development is
postulated to be driven by the accumulation of genetic errors in
the target tissue (27–29), it was of interest to determine whether
hallmarks of genetic instability such as chromosome polysomy
could be detected at higher frequencies in tissues thought to be
associated with higher risk for cancer development.
The results reported in this study (Table 2) demonstrated
that the levels of chromosome polysomy were higher in biop-
sies from “high-risk” sites compared with those taken from
“low-risk” sites. Whereas this might have been expected on the
presence of a higher frequency of dysplastic lesions in the
high-risk sites, this difference in chromosome polysomy levels
between high- and low-risk sites remained when only hyper-
plastic lesions were considered. Nevertheless, a considerable
degree of overlap of chromosome polysomy levels existed
between high- and low-risk lesions, suggesting that measures of
genetic instability might provide additional risk information to
that of site location.
The results reported in this study also demonstrated that,
whereas the levels of chromosome polysomy were generally
higher in dysplastic epithelium than in hyperplastic epithelium,
a high degree of variation of chromosome polysomy was de-
tectable within each histological class. However, hyperplastic
Fig. 4. Detection of high chromosome polysomy in hyperplastic regions of
biopsies containing dysplasia. A, H&E showing an epithelial region of hyperpla-
sia adjacent to dysplasia; B, CISH analysis of the marked hyperplastic region of
Fig. 3A showing frequent cells with three chromosome 9 signals in the basal and
parabasal layers (31000); C, chromosome copy map representation of the same
area shown in Fig. 4B demonstrating the epithelial location of cells with three
chromosome 9 signals (red-colored dots). Note the preferential localization of
polysomic cells in the basal and parabasal epithelial layers.
Fig. 5. Comparison of chromosome polysomy levels between basal/parabasal
and superficial epithelial layers in lesions exhibiting (left) or not exhibiting (right)
koilocytosis. Note the more frequent retention of cells exhibiting chromosome
polysomy into the superficial epithelial layers in lesions with koilocytosis.
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regions in biopsies that also showed dysplasia in another loca-
tion exhibited chromosome polysomy levels more comparable
with those found in dysplasia. These levels were considerably
higher than those found in hyperplastic regions in biopsies
without evident dysplasia. These results suggest that measure-
ments of chromosome polysomy might reflect the ongoing
process of generalized genetic instability in the carcinogen-
exposed tissue and, therefore, might provide risk assessments
that are somewhat independent of the histological appearance
of that particular lesion. Indeed, head and neck tumorigenesis
has been proposed to represent a field cancerization process
whereby a whole tissue field is exposed to carcinogen insult and
is at increased cancer risk throughout the field.
One of the issues facing the use of biomarkers for head and
neck cancer risk assessment is knowing the most informative
site for biopsy. Whereas individuals with oral premalignant
lesions in high-risk sites are known to be at increased risk for
cancer development and whereas the finding of epithelial dys-
plasia is associated with increased cancer risk, the cancers that
do subsequently develop are frequently located away from the
site of the premalignant lesion. Thus, biomarkers are needed
that can provide risk information from assessments of random
biopsies from the tissue at risk. Our previous studies (13)
demonstrated that normal and premalignant lesions adjacent to
head and neck cancers exhibited significant degrees of genetic
instability when assayed by CISH. The present study reinforces
our prior observations that significant degrees of chromosome
polysomy can also be found in premalignant lesions in subjects
at increased cancer risk (14, 15). Moreover, the finding of
increased chromosome polysomy levels in hyperplastic lesions
in the field of dysplastic lesions further supports the possibility
that chromosome polysomy measurements can provide a more
global assessment of the forces driving the tumorigenesis proc-
ess in the tissue field and thus provide additional risk informa-
tion to lesion site and histology.
A number of driving forces are likely to be involved in head
and neck tumorigenesis, including the degree of tobacco and
alcohol exposure. Unfortunately, the number of cases examined in
this study was not enough to explore the relationship between
carcinogen exposure and the degree of ongoing chromosome poly-
somy. However, oral leukoplakia is associated with a number of
identifiable or unidentifiable factors in addition to tobacco or
alcohol exposure, including tissue irritants, nutritional deficien-
cies, and viral infections. Whereas these associated factors may or
may not induce genetic instability on their own, they may play a
synergistic role in the accumulation of genetic damage by pro-
moting cell proliferation or preventing the loss of genetically
altered cells. During the course of this study, a number of koilo-
cytotic regions were detected in the biopsied lesions. Koilocytosis
is normally found in association with HPV infection. However, the
role of HPV infection in the etiology of head and neck cancer is
still uncertain (19, 30–32). Unfortunately, insufficient biopsy ma-
terial was available from these biopsies to assess HPV status or
HPV-associated gene expression.
Nevertheless, the results reported in this study suggest that
although koilocytotic lesions did not necessarily exhibit in-
creased overall levels of chromosome polysomy, they were
associated with a different spatial pattern of chromosome poly-
somy within the epithelium. In particular, the levels of chro-
mosome polysomy in koilocytotic lesions frequently remained
the same or increased in the superficial layers when compared
with the basal/parabasal layers. In nonkoilocytotic lesions, the
levels of chromosome polysomy appeared to decrease as cells
moved into the superficial layers. The reason for these different
patterns of chromosomal polysomy in koilocytotic lesions com-
pared with nonkoilocytotic lesions is not well understood.
However, a number of possible explanations exist. Most car-
cinogens are known to induce chromosome damage in exposed
cells (33), leading to the up-regulation of cell cycle checkpoints
that would either slow subsequent cell growth (34) or induce
cell loss of the damaged cells (35). However, the HPV E6 gene
product is known to target p53 for proteosome-mediated deg-
radation (36–38), and the HPV E7 gene product is known to
inactivate retinoblastoma protein function (39–41). Thus, in-
activation of these checkpoint controls in HPV-associated
koilocytotic lesions might result in the retention of genetically
damaged cells into the superficial layers of the epithelium (42,
43). Indeed, our group has also found that altered p53 expres-
sion in oral premalignant lesions is associated with increased
chromosome polysomy (44). Alternatively, HPV-associated E6
and E7 expression might cause genetic instability through dys-
regulation of centrosomal duplication, leading to mitotic errors
(45). Thus, HPV infection or other factors that mimic HPV-
induced dysfunction (e.g., disruption of p53 function) might
interact synergistically with chronic carcinogen exposure to
promote chromosome instability in the epithelium.
In summary, the results of this study suggest that measures
of ongoing genetic instability such as chromosome polysomy
might provide additional insight into head and neck cancer risk
assessment beyond that of the location and histology of the
Fig. 6. Example of retention of cells with chromosome polysomy into the
superficial epithelial layers of a koilocytotic lesion. A, H&E of a koilocytotic area
showing pyknotic nuclei and perinuclear halos (3400); B, chromosome copy map
of the same area shown in Fig. 6A demonstrating the presence of polysomic cells
(red dots) dispersed throughout the epithelial thickness.
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premalignant lesion. The finding that hyperplastic lesions in the
field of dysplastic lesions show relatively high levels of chro-
mosome polysomy suggests that this assay measures the level
of ongoing genetic instability in the tissue field at risk and thus
is an indication of the forces that drive head and neck tumor-
igenesis. Furthermore, the finding that chromosome polysomy
is propagated in koilocytotic epithelium suggests that epige-
netic factors might synergistically interact with extrinsic carci-
nogenic exposure in the accumulation of genetic hits important
for tumor development. Additional long-term follow-up studies
are required to determine whether the levels of chromosome
polysomy in oral premalignant lesions add significantly to the
determination of head and neck cancer risk.
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